26 completed, 3 terminated, 3 unknown, 2 recruiting. 35 Phase 2, 6 Phase 3, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 35 | Completed 26, Terminated 3, Unknown 3, Recruiting 2, Withdrawn 1 |
| Phase 3 | 6 | Completed 2, Unknown 2, Recruiting 1, Terminated 1 |
| Phase 1 | 4 | Completed 3, Withdrawn 1 |
Follow Fluconazole: new trials by email Literature Review of Fluconazole trials Research Report on Fluconazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients WXSH0102/placebo, fluconazole capsules/placebo - Vaginitis | Phase 2 | Recruiting | Cisen Pharmaceutical CO., LTD. | 108 | 2025-01-13 | 2025-02-13 |
| A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis Chlorhexidine Gluconate, Fluconazole - Candidiasis, Vulvovaginal | Phase 2 | Unknown | Karolinska Institutet | 60 | 2022-04-27 | 2022-05-20 |
| Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels Fluconazole, Placebo - Nephrolithiasis, Nephrocalcinosis | Phase 2 | Completed | Hospices Civils de Lyon | 56 | 2021-01-13 | 2024-07-12 |
| A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis | Phase 2 / Phase 3 | Unknown | ProFem GmbH | 432 | 2019-10-01 | 2022-09-22 |
| Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia Single dose liposomal Amphotericin and Fluconazole, Fluconazole - Cryptococcal Meningitis | Phase 2 / Phase 3 | Recruiting | Makerere University | 356 | 2019-06-20 | 2026-04-28 |
| Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease Vancomycin, Neomycin, Ciprofloxacin - Crohn Disease | Phase 2 | Completed | Children's Hospital of Philadelphia | 10 | 2018-07-12 | 2022-02-09 |
| Treatment With Tamoxifen in Cryptococcal Meningitis Tamoxifen, Amphotericin B, Fluconazole - Meningitis Streptococcal, Hiv | Phase 2 | Completed | Oxford University Clinical Research Unit, Vietnam | 50 | 2017-10-10 | 2019-12-02 |
| Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis Fluconazole, SCY-078 - Candida Vulvovaginitis | Phase 2 | Completed | Scynexis, Inc. | 186 | 2017-08-01 | 2021-08-12 |
| Safety and Pharmacokinetics of Oral F901318 (Fluconazole and Posaconazole) IN Aml Leukaemia F901318 with fluconazole low dose, F901318 with fluconazole high dose, F901318 with posaconazole - Acute Myeloid Leukemia | Phase 1 / Phase 2 | Withdrawn | F2G Ltd | 2017-03-01 | 2018-02-15 | |
| Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Oral Encochleated Amphotericin B (CAMB), Fluconazole - Vulvovaginitis, Yeast Infection | Phase 2 | Completed | Matinas BioPharma Nanotechnologies, Inc. | 137 | 2016-11-01 | 2018-11-02 |
| Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease Fluconazole, Vancomycin, Neomycin - Crohn's Disease | Phase 2 | Completed | University of Pennsylvania | 8 | 2016-08-01 | 2024-02-06 |
| CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension CD101, Caspofungin, Fluconazole - Candidemia, Mycoses | Phase 2 | Completed | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 207 | 2016-07-26 | 2020-12-08 |
| RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections CD101 Vaginal Gel (3%), CD101 External gel (1%), CD101 Vaginal Ointment (6%) - Candidiasis, Vulvovaginal, Mycoses | Phase 2 | Completed | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 126 | 2016-06-08 | 2020-08-31 |
| Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis SCY-078, Fluconazole - Vulvovaginal Candidiasis | Phase 2 | Completed | Scynexis, Inc. | 96 | 2015-11-01 | 2019-07-12 |
| Fluconazole Versus Micafungin in Neonates With Candidiasis Fluconazole, Micafungin - Candidiasis | Phase 2 / Phase 3 | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 100 | 2014-10-01 | 2025-09-04 |
| Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis SCY-078, Fluconazole, Micafungin - Mycoses, Candidiasis, Invasive | Phase 2 | Completed | Scynexis, Inc. | 27 | 2014-09-01 | 2024-06-25 |
| Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies Zinc Sulfate Oral Product, Levofloxacin 500Mg Oral Tablet, Fluconazole 200mg tab - Stem Cell Transplant Complications | Phase 2 | Completed | Azienda Ospedaliero, Universitaria Pisana | 20 | 2014-01-01 | 2020-01-07 |
| Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection Flucytosine and fluconazole, Fluconazole - Cryptococcal Infection Disseminated | Phase 2 | Terminated | Yale University | 6 | 2013-09-01 | 2021-09-29 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) VT-1161, Fluconazole - Candidiasis, Vulvovaginal | Phase 2 | Completed | Viamet | 55 | 2013-08-01 | 2018-08-01 |
| Pharmacokinetic Study of Fluconazole in Premature Infants Fluconazole - Very Low Birth Weight Infant | Phase 2 | Completed | Seoul National University Hospital | 80 | 2012-09-01 | 2014-11-19 |
Showing 20 of 35. Sign in to see all of them.
Candidiasis, Vulvovaginal (7) · Meningitis, Cryptococcal (7) · HIV Infections (6) · Mycoses (6) · Crohn Disease (3) · Meningitis (3) · AIDS-Related Opportunistic Infections (2) · Acquired Immunodeficiency Syndrome (2) · Candidemia (2) · Candidiasis (2) · Candidiasis, Invasive (2) · Cryptococcosis (2) · Rare Diseases (2) · Sporotrichosis (2) · Vulvovaginitis (2)
National Institute of Allergy and Infectious Diseases (NIAID) (4) · Scynexis, Inc. (3) · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · ANRS, Emerging Infectious Diseases (1) · Azienda Ospedaliero, Universitaria Pisana (1) · Children's Hospital of Philadelphia (1) · Cisen Pharmaceutical CO., LTD. (1) · Emory University (1) · F2G Ltd (1) · Hospices Civils de Lyon (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · InterMune (1) · Johns Hopkins University (1) · Karolinska Institutet (1) · Makerere University (1)
United States (17) · France (4) · Belgium (3) · Italy (3) · Spain (3) · Thailand (3) · Canada (2) · Dominican Republic (2) · Germany (2) · Guatemala (2) · Honduras (2) · Kenya (2) · Peru (2) · South Africa (2) · Uganda (2)
David Angulo, MD (3) · Lindsey Albenberg, DO (2) · William Dismukes (2) · Alena Jandourek, MD (1) · Ana-Claire L Meyer, MD, MSHS (1) · Arnold M. Markoe, MD, ScD (1) · Arshed A Quyyumi, MD (1) · Cathrin Alvendal, MD, PhD (1) · David N Herndon, MD (1) · Douglas Kling (1) · Han-Suk Kim, MD, PhD (1) · Herbert Kiss, Prof. (1) · J Jacobson (1)
PMID 16505648, PMID 19172247, PMID 19441980, PMID 19734776, PMID 19897055, PMID 20881067, PMID 21555712, PMID 22463890, PMID 22606232, PMID 22895351, PMID 23150682, PMID 23303450, PMID 24009246, PMID 24298851, PMID 24655871, PMID 24675657, PMID 24824900, PMID 24918945, PMID 24925526, PMID 25211297, PMID 25514427, PMID 25648989, PMID 25807408, PMID 27171844, PMID 27433905, PMID 28240622, PMID 29744900, PMID 29747074, PMID 30801037, PMID 30910892, PMID 32818963, PMID 32955088, PMID 33922391, PMID 34555149, PMID 34581270, PMID 35710560, PMID 36396498, PMID 36780493, PMID 38008099, PMID 38502709, PMID 39044381, PMID 39468640, PMID 39529079, PMID 40970688, PMID 41845293, PMID 41940006
2008 (1), 2015 (1), K23DK109136 (1), P30MH075673 (1), P50GM060338 (1), R01HL079115 (1), R21NS077858 (1)